Eli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy

This week on "The Readout LOUD" podcast: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

This week on "The Readout LOUD" podcast: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy.
Source
Stat News
Opens original article in a new tab

(MedPage Today) -- CHICAGO -- Classifying inflammatory subphenotypes of acute respiratory distress syndrome (ARDS) with bedside lab testing was feasible and showed differences in 60-day mortality, according to a prospective cohort study. Among...

(MedPage Today) -- Retrospective data showed that resuming direct oral anticoagulants (DOACs) 2 days or more following an elective colonoscopy was linked with a higher risk of thromboembolic events without a reduction in gastrointestinal bleeding...

In today's Readout Newsletter, Denali and Corcept win FDA approvals, Sarepta eyes a rebound, and Allogene progresses with an off-the-shelf CAR-T.

In this week's STATus Report, influential health communicators Jessica Knurick, Morgan “Dr. Noc” McSweeney, and Jessica Malaty Rivera chat about the mental health impacts of social media.